Vivex Biomedical, Inc. — Form D/A

Vivex Biomedical, Inc. of ATLANTA, GA, a company, filed a Form D amendment with the SEC on 2017-05-11. The offering totals $7.0M, of which $6.3M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (34)

Showing 25 of 34 people.

NameRoleLocation
Tracy S AndersonDirectorAtlanta, GA
U. Bertram Ellis, Jr.DirectorAtlanta, GA
J. Miguel Fernandez de CastroDirectorAtlanta, GA
John A McCallumDirectorAtlanta, GA
Richard E PerlmanDirectorCHICAGO, IL
James K PriceDirectorCHICAGO, IL
Barry Thomas SalzmanDirectorAtlanta, GA
Timothy S TaylorDirectorAtlanta, GA
Tracy S AndersonExecutive OfficerAtlanta, GA
Timothy Thomas Ganey, Ph.D.Executive OfficerAtlanta, GA
Stuart J KomenskiExecutive OfficerAtlanta, GA
Holly S MasonExecutive OfficerAtlanta, GA
Dr. H Thomas TempleExecutive OfficerAtlanta, GA
Tracy AndersonDirectorLos Angeles, CA
Tracy AndersonExecutive OfficerLos Angeles, CA
John MarshExecutive OfficerHouston, TX
Jeffrey A SmithDirectorCarrollton, GA
Michael RozmajzlExecutive OfficerMilton, GA
TIMOTHY TAYLORDirectorNew York, NY
THOMAS J GIBSONExecutive OfficerATLANTA, GA
Leo S CookExecutive OfficerAtlanta, GA
Timothy J TaylorDirectorSacramento, CA
Dr. H. Thomas TempleExecutive OfficerMarietta, GA
Barry J SalzmanDirectorMarietta, GA
Ricardo J NunezExecutive OfficerMarietta, GA

Other filings by this issuer (4)

FiledFormOfferingSold
2017-01-26D$5.0M
2016-01-05D$10.0M$6.6M
2013-09-16D/A$7.2M$7.2M
2013-07-18D$5.5M$2.2M

More